The FDA first approved Wegovy as a diabetes drug, but researchers have since found that it has other health benefits, including for your heart. Wegovy's approval for heart disease The FDA originally approved We
参考来源：‘Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity’，新闻稿。Novo Nordisk；2024年3月9日发布。注：本文旨在介绍医药健康研究，不作任何用药依据，具体用药指引，请咨询主治医师。
The FDA's approval expands the use of semaglutide to people with a BMI of 27 or higher (qualified as overweight or obese) with a history of cardiac events. But it's unknown whether the drug would work as well at preventing cardiovascular disease in people with lower B...
参考来源:‘Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity’,新闻稿。Novo Nordisk;2024年3月9日发布。 注:本文旨在介绍医药健康研究,不作任何用药依据,具体用药指引,请咨询主治医师。
The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works
参考来源:‘Wegovy receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity’,新闻稿。Novo Nordisk。 注:本文旨在介绍医药健康研究,不作任何用药依据,具体用药指引,请咨询主治医师。
"If this same drug also receives FDA approval to treat diabetes or reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, then it would be considered a Part D drug for those specific uses only," t...
参考来源:‘Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity’,新闻稿。Novo Nordisk;2024年3月9日发布。 注:本文旨在介绍医药健康研究,不作任何用药依据,具体用药指引,请咨询主治医师。...
The approval demonstrates the significant downstream health benefits of Wegovy — and potentially similar drugs — for severe conditions caused by excess weight. Obesity increases the risk of several conditions, such as diabetes, heart disease and even some cancers. ...
coverweight-loss drugs, although Congress is facing pressure to change that,CNNreported. But if the medication also receives FDA approval to lower the chances of heart attacks, strokes and other cardiovascular events, it can be added to Part D programs for people with heart dise...